Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSolGold Regulatory News (SOLG)

  • This share is currently suspended. It was suspended at a price of 27.95
  • There is currently no data for SOLG

Form 8.3 - SolGold plc

9 Jan 2026 11:11

RNS Number : 3620O
Societe Generale SA
09 January 2026
 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

(a) Full name of discloser:

SOCIETE GENERALE SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SolGold plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

08/01/2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 32,477,925

1.08

 0

0.00

(2) Cash-settled derivatives:

 

 0

0.00

 28,148,680

0.93

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 0

0.00

 0

0.00

TOTAL:

 32,477,925

1.08

 28,148,680

0.93

 

 

 

 

 

 

All interests and all short positions should be disclosed.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

GBP

1p ordinary

Purchase

 10,117,625

0.278

1p ordinary

Sale

 667,097

0.27816

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP

1p ordinary

CFD

Increasing a short position

 10,117,625

0.278

1p ordinary

CFD

Reducing a short position

 667,097

0.27816

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements, or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

09/01/2026

Contact name:

Paul Jenkins

Telephone number:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETAKCBDDBKDKDK
Date   Source Headline
17th Sep 20257:00 amRNSDrilling Reports at Tandayama
1st Sep 20257:00 amRNSTransition of Corporate Domicile
19th Aug 20254:44 pmRNS-RAnnounces Canaccord Genuity Engagement
15th Aug 20257:00 amRNSExceptional Near-Surface Intercepts at Tandayama
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20257:00 amRNSMultiple High-Grade Intervals at Tandayama-América
21st Jul 20257:00 amRNS$33.3M Received from Franco-Nevada & OR Royalties
17th Jul 20257:00 amRNSProject Execution Plan
10th Jul 20257:00 amRNSUS$33.3M Second Advance Under Stream Financing
4th Jun 20253:53 pmRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSVoluntary Delisting from Toronto Stock Exchange
16th May 20257:00 amRNSQ3 Financial Report and Quarterly MD&A
12th May 20257:03 amRNSEnvironmental Licence Granted for Porvenir Project
1st May 20257:00 amRNSCascabel Amended Investment Protection Agreement
15th Apr 20256:14 pmRNSDirector/PDMR Shareholding
15th Apr 20253:10 pmRNSSolGold Early Production Open Pit Strategy
27th Mar 20252:37 pmRNSHolding(s) in Company
26th Mar 20255:56 pmRNSHolding(s) in Company
24th Mar 20257:03 amRNSJiangxi Copper Investment Conditions Satisfied
14th Mar 20257:00 amRNSAppointment of Senior Independent Director
12th Mar 20258:01 amRNSFurther Investment from Jiangxi Copper
4th Mar 20258:00 amRNSNew CEO and Chair, and Re-Setting Company Strategy
21st Feb 202510:15 amRNSStatement re Litigation with Ex-CEO
14th Feb 20257:00 amRNSQ2 Financial Report and Quarterly MD&A
14th Jan 20256:11 pmRNSBlock Listing Six Monthly Return
5th Dec 20244:58 pmRNSResult of AGM
28th Nov 20246:00 pmRNSShareholder Update on Voting Process
18th Nov 20247:00 amRNSKey Milestones and Outlook for the Year Ahead
15th Nov 20247:13 amRNSQ1 Financial Report and Quarterly MD&A
7th Nov 20242:39 pmRNSNotice of AGM
4th Nov 20247:00 amRNSGeotechnical Investigations Commence at Cascabel
28th Oct 20247:00 amRNSCascabel Project Update
16th Oct 20247:00 amRNSCompany Update
27th Sep 20247:00 amRNSRelease of FY24 Annual Report and Accounts
16th Sep 20247:00 amRNSCompany Update
14th Aug 20244:57 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSCascabel Project Update
12th Aug 20243:30 pmRNSDirector/PDMR Shareholding
1st Aug 20246:20 pmRNSDirector/PDMR Shareholding
26th Jul 202412:08 pmRNSBlock Listing Six Monthly Return
18th Jul 20245:25 pmRNSPDMR Dealing
15th Jul 20247:00 amRNSUS$750M Financing Package for the Cascabel Project
25th Jun 20244:15 pmRNSFinancing Update
6th Jun 20247:00 amRNSExploitation Contract for Cascabel Project
16th May 20247:00 amRNSThird-Quarter Financial Report and Quarterly MD&A
14th May 20247:00 amRNSKey Financial Developments
15th Apr 20245:17 pmRNSDirector/PDMR Shareholding
12th Apr 20244:00 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSBlanca-Nieves Project Update
12th Mar 20247:00 amRNSPre-Feasibility Study Technical Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.